Search

everythinglearnresearchcommunity

for

Search:↓

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Topical tofacitinib is effective and safe for treating alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Non-immune factors play a significant role in alopecia areata.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Bimatoprost is slightly more effective than minoxidil for eyebrow growth, and both are safe.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

Isotretinoin was not effective in treating facial lichen planopilaris.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.